Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

NCT07516288 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Dilated Cardiomyopathy (DCM)
Heart Failure

Interventions

BIOLOGICAL: FAP immunosuppressive CAR-DC

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University